99%+ Purity Oral Pill & Tablet Steroid Tamoxifen Pure Powder
Product Details:
| Tamoxifen Powder Information | ||
| Tamoxifen Price | 100g | According to your needs |
| 500g | According to your needs | |
| 1000g | According to your needs | |
| Steroid packaging | Special stealth packaging through Customs | |
| Delivery time | About 7 days | |
| Shipping | EMS, Hongkong Post, DHL, TNT, Fedex | |
| Payment terms | WU, MG, Bitcoin, T/T | |
| Minimum order | 10g | |
99%+ Purity Oral Pill & Tablet Steroid Tamoxifen Pure Powder
Product Name: Tamoxifen Powder
CAS #: 10540-29-1
Synonyms:TMX;Nolvadex
Purity: ≥99%
Tamoxifen Price: According to your needs
Tamoxifen Half Life: Around 5-7 Days
Tamoxifen dosage: For the treatment of metastatic breast cancer in women and men:
20 to 40 mg orally Dosages greater than 20 mg should be given in divided doses (morning and evening).
For the treatment of women with Ductal Carcinoma in Situ, following breast surgery and radiation:
20 mg orally daily for 5 years.
To reduce the incidence of breast cancer in women at high risk for breast cancer:
20 mg orally daily for 5 years.
Usual Adult Dose for Breast Cancer - Adjuvant:
For the treatment of node-positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation:
10 mg orally 2 to 3 times a day for 5 years.
Usual Adult Dose for Breast Cancer - Palliative:
10 to 20 mg orally twice a day
A beneficial response may not be evident for several months after initiation of therapy.
Usual Pediatric Dose for McCune-Albright Syndrome:
For use in girls age 2 to 10 years with McCune-Albright Syndrome and precocious puberty:
20 mg once a day. The duration of treatment is up to 12 months.
Usual Pediatric Dose for Precocious Puberty:
For use in girls age 2 to 10 years with McCune-Albright Syndrome and precocious puberty:
20 mg once a day. The duration of treatment is up to 12 months.
Tamoxifen Detection Time: 2 months
Tamoxifen Side Effect: Signs of a stroke - sudden numbness or weakness (especially on one side of the body), sudden severe headache, slurred speech, problems with vision or balance;signs of a blood clot in the lung - chest pain, sudden cough, wheezing, rapid breathing, coughing up blood; or signs of a blood clot in your leg - pain, swelling, warmth, or redness in one or both legs.
Tamoxifen Results: Tamoxifen reduced the risk of breast cancer by 38% in women who didn’t take hormone replacement therapy;tamoxifen reduced the risk of estrogen-receptor-positive disease by 45% in women who didn’t take hormone replacement therapy
Tamoxifen Specifications:
COA
Product name | Tamoxifen citrate (Nolvadex) | |
Appearance | White crystalline powder | |
Identification | IR , UV conform | Conform |
Loss on drying | ≤0.5ml | 0.21ml |
Residue on ignition | Not more than 0.2% | 0.07ml |
Iron | Not more than 0.005% | 0.0017% |
Heavy metals | Not more than 0.001% | 0.0006% |
Related substances | Total: Not more than 1.0% | 0.35% |
E-isomer | Not more than 0.3% | 0.18% |
Organic volatile impurities | Conforms | Conforms |
Assay | 99.0~101.0% | 99.6% |
Tamoxifen Descriptions:
Tamoxifen blocks the actions of estrogen, a female hormone. Certain types of breast cancer require estrogen to grow.
Tamoxifen is used to treat some types of breast cancer in men and women. It is also used to lower a woman's chance of developing breast cancer if she has a high risk (such as a family history of breast cancer).
Tamoxifen may also be used for purposes not listed in this medication guide.
Tamoxifen Effects:
Tamoxifen, as any other drug, particularly anticancer drugs, has side effects. Compared with chemotherapeutic regimens commonly used for the treatment of advanced breast cancer, tamoxifen appears to be much safer and to be considerably better tolerated by the patient. Clearly, the issue related to tamoxifen use becomes one of weighing the benefits vs the risks. On the positive side, tamoxifen has beneficial effects on bone and lipids which, in conjunction with the reduction in contralateral breast cancer, will translate into lives saved. On the negative side, tamoxifen has an association with an increase in the detection of endometrial cancer.
If we add the most clinically significant benefits of tamoxifenthat is, its ability to prolong disease-free survival and to reduce breast cancer mortalitythen it becomes clear that the benefits of tamoxifen therapy far outweigh the risks. Tamoxifen is listed by the World Health Organization as an essential drug for the treatment of breast cancer. Indeed, an agency of the World Health Organization recently reviewed all the information concerning the links between tamoxifen and carcinogenesis and concluded that the known benefits of tamoxifen far outweigh any risks from side effects. No woman with breast cancer should be denied tamoxifen out of concern for potential gynecologic complications.
